Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private...
Source: prnewswire.com